Beurs gesloten -
Nyse
22:00:02 17-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
26,09
USD
|
+0,93%
|
|
+4,11%
|
-4,36%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
21.221
|
18.071
|
15.374
|
11.668
|
11.946
|
11.339
|
-
|
-
|
Bedrijfswaarde
1 |
22.991
|
19.999
|
17.423
|
14.190
|
11.946
|
13.895
|
13.569
|
13.243
|
K/w-verhouding
|
35,5
x
|
40,3
x
|
29,3
x
|
52,6
x
|
45,6
x
|
22,1
x
|
16,9
x
|
14,3
x
|
Dividendrendement
|
1,54%
|
1,82%
|
2,14%
|
2,79%
|
-
|
2,94%
|
3,3%
|
3,7%
|
Marktkapitalisatie/omzet
|
4,13
x
|
3,96
x
|
2,95
x
|
2,24
x
|
2,15
x
|
1,95
x
|
1,85
x
|
1,76
x
|
Bedrijfswaarde/omzet
|
4,47
x
|
4,39
x
|
3,34
x
|
2,72
x
|
2,15
x
|
2,39
x
|
2,22
x
|
2,05
x
|
Bedrijfswaarde/EBITDA
|
14,9
x
|
18
x
|
13
x
|
10,7
x
|
8,16
x
|
9,36
x
|
8,3
x
|
7,7
x
|
Bedrijfswaarde/FCF
|
30,3
x
|
40,6
x
|
37,1
x
|
129
x
|
-
|
24,6
x
|
19,5
x
|
17,5
x
|
FCF Yield
|
3,31%
|
2,46%
|
2,69%
|
0,78%
|
-
|
4,06%
|
5,14%
|
5,71%
|
Price to Book
|
4,15
x
|
3,43
x
|
2,76
x
|
2,23
x
|
-
|
2,1
x
|
2
x
|
1,91
x
|
Aantal aandelen (in duizenden)
|
873.334
|
875.215
|
878.536
|
869.496
|
870.199
|
871.947
|
-
|
-
|
Referentieprijs
2 |
24,30
|
20,65
|
17,50
|
13,42
|
13,73
|
13,00
|
13,00
|
13,00
|
Datum van publicatie
|
20/02/20
|
18/02/21
|
22/02/22
|
21/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
5.138
|
4.560
|
5.212
|
5.215
|
5.549
|
5.817
|
6.121
|
6.454
|
EBITDA
1 |
1.544
|
1.108
|
1.345
|
1.324
|
1.464
|
1.484
|
1.634
|
1.719
|
Bedrijfsresultaat (EBIT)
1 |
1.169
|
683
|
936
|
901
|
970
|
1.059
|
1.219
|
1.333
|
Operationele Marge
|
22,75%
|
14,98%
|
17,96%
|
17,28%
|
17,48%
|
18,21%
|
19,92%
|
20,65%
|
Resultaat voor belastingen (EBT)
1 |
743
|
246
|
586
|
235
|
290
|
636,8
|
818,4
|
957,2
|
Nettowinst (verlies)
1 |
600
|
448
|
524
|
223
|
263
|
540,9
|
693,7
|
784,8
|
Nettomarge
|
11,68%
|
9,82%
|
10,05%
|
4,28%
|
4,74%
|
9,3%
|
11,33%
|
12,16%
|
WPA
2 |
0,6840
|
0,5120
|
0,5970
|
0,2550
|
0,3010
|
0,5890
|
0,7705
|
0,9091
|
Free Cash Flow
1 |
760
|
492
|
469
|
110
|
-
|
563,9
|
697,4
|
756,8
|
FCF-marge
|
14,79%
|
10,79%
|
9%
|
2,11%
|
-
|
9,69%
|
11,39%
|
11,73%
|
Kasstroomconversie (ebitda)
|
49,22%
|
44,4%
|
34,87%
|
8,31%
|
-
|
38,01%
|
42,68%
|
44,02%
|
Kasstroomconversie (nettowinst)
|
126,67%
|
109,82%
|
89,5%
|
49,33%
|
-
|
104,25%
|
100,54%
|
96,44%
|
Dividend per aandeel
2 |
0,3750
|
0,3750
|
0,3750
|
0,3750
|
-
|
0,3822
|
0,4286
|
0,4817
|
Datum van publicatie
|
20/02/20
|
18/02/21
|
22/02/22
|
21/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 S1
|
2025 S2
|
---|
Omzet
1 |
2.653
|
2.035
|
2.525
|
2.599
|
1.266
|
1.346
|
2.613
|
1.306
|
1.293
|
2.600
|
1.250
|
1.365
|
2.615
|
1.356
|
1.379
|
2.734
|
1.357
|
1.458
|
2.815
|
1.398
|
1.450
|
2.830
|
1.429
|
1.548
|
2.988
|
1.464
|
2.994
|
3.142
|
EBITDA
|
825
|
360
|
748
|
666
|
-
|
-
|
679
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
|
637
|
172
|
511
|
459
|
-
|
-
|
477
|
-
|
-
|
440
|
-
|
-
|
461
|
-
|
-
|
417
|
-
|
-
|
553
|
-
|
-
|
466,5
|
-
|
-
|
551,6
|
-
|
596
|
644
|
Operationele Marge
|
24,01%
|
8,45%
|
20,24%
|
17,66%
|
-
|
-
|
18,25%
|
-
|
-
|
16,92%
|
-
|
-
|
17,63%
|
-
|
-
|
15,25%
|
-
|
-
|
19,64%
|
-
|
-
|
16,49%
|
-
|
-
|
18,46%
|
-
|
19,91%
|
20,5%
|
Resultaat voor belastingen (EBT)
|
360
|
-34
|
280
|
223
|
-
|
-
|
-
|
-
|
-
|
204
|
-
|
-
|
31
|
-
|
-
|
211
|
-
|
-
|
79
|
-
|
-
|
256
|
-
|
-
|
392,5
|
-
|
399
|
446
|
Nettowinst (verlies)
|
291
|
100
|
348
|
205
|
-
|
-
|
319
|
-
|
-
|
177
|
-
|
-
|
46
|
-
|
-
|
171,6
|
-
|
-
|
91
|
-
|
-
|
206
|
-
|
-
|
316
|
-
|
321
|
359
|
Nettomarge
|
10,97%
|
4,91%
|
13,78%
|
7,89%
|
-
|
-
|
12,21%
|
-
|
-
|
6,81%
|
-
|
-
|
1,76%
|
-
|
-
|
6,28%
|
-
|
-
|
3,23%
|
-
|
-
|
7,28%
|
-
|
-
|
10,57%
|
-
|
10,72%
|
11,43%
|
WPA
|
0,3320
|
0,1140
|
0,3980
|
0,2330
|
-
|
-
|
0,3640
|
-
|
-
|
0,2020
|
-
|
-
|
0,0530
|
-
|
-
|
0,1970
|
-
|
-
|
0,1040
|
-
|
-
|
0,2200
|
-
|
-
|
0,3700
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0,1440
|
-
|
-
|
0,2310
|
-
|
-
|
0,1440
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
20/02/20
|
29/07/20
|
18/02/21
|
29/07/21
|
4/11/21
|
22/02/22
|
22/02/22
|
28/04/22
|
28/07/22
|
28/07/22
|
3/11/22
|
21/02/23
|
21/02/23
|
3/05/23
|
3/08/23
|
3/08/23
|
2/11/23
|
27/02/24
|
27/02/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
1.770
|
1.928
|
2.049
|
2.522
|
-
|
2.555
|
2.229
|
1.904
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
1,146
x
|
1,74
x
|
1,523
x
|
1,905
x
|
-
|
1,722
x
|
1,364
x
|
1,107
x
|
Free Cash Flow
1 |
760
|
492
|
469
|
110
|
-
|
564
|
697
|
757
|
ROE (netto-inkomsten/eigen vermogen)
|
17,8%
|
10,8%
|
13,1%
|
13,2%
|
-
|
14,1%
|
15,9%
|
16,6%
|
ROA (netto-inkomsten/totale activa)
|
10,3%
|
5,55%
|
6,47%
|
6,83%
|
-
|
6,2%
|
7,85%
|
8,5%
|
Totale activa
1 |
5.831
|
8.072
|
8.093
|
3.266
|
-
|
8.725
|
8.836
|
9.232
|
Nettoactief per aandeel
2 |
5,860
|
6,020
|
6,350
|
6,030
|
-
|
6,180
|
6,500
|
6,810
|
Cashflow per aandeel
2 |
1,330
|
1,070
|
1,000
|
0,5400
|
-
|
1,270
|
1,440
|
1,180
|
Capex
1 |
408
|
443
|
408
|
358
|
-
|
449
|
464
|
483
|
Capex/omzet
|
7,94%
|
9,71%
|
7,83%
|
6,86%
|
-
|
7,72%
|
7,59%
|
7,48%
|
Datum van publicatie
|
20/02/20
|
18/02/21
|
22/02/22
|
21/02/23
|
27/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Gemiddelde koersdoel
16,35
USD Spread / Gemiddelde doel +25,69% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +11,76% | 127 mld. | | +4,02% | 9,04 mld. | | +38,12% | 5,56 mld. | | -23,70% | 4,72 mld. | | +8,55% | 3,45 mld. | | -6,44% | 2,86 mld. | | -5,85% | 2,07 mld. | | -11,84% | 2,04 mld. | | -23,36% | 1,77 mld. |
Medische hulpmiddelen & implantaten
|